GenVivo, Inc.
We are a clinical stage company with an off-the-shelf, vector-based platform, for immunotherapeutics in oncology
San Marino, United States
53 employees
Biotechnology, Health Care
General Information
Get notified when GenVivo, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track GenVivo, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About GenVivo, Inc.
Taxonomy: oncology, immunotherapeutics, gene delivery technologies, cancer treatment, clinical-stage company, patient treatment experience, off-the-shelf therapies, novel gene therapies, companion diagnostics, immunotherapies, clinical-stage cancer companies, cancer vaccines, tumor-killing therapies, patient survival, quality of life improvement
No funding data available for GenVivo, Inc. yet.
Get notified when GenVivo, Inc. raises fundingGenVivo, Inc. Alternatives & Competitors
Accelerating access to Cell & Gene Therapies
Pioneering precision cancer therapies with advanced molecular targeting technology for improved pati...
Genprex is a gene therapy company focused on developing life-changing technologies for patients with...
FAQ About GenVivo, Inc.
Don't just browse. Track.
Signal Tracker monitors GenVivo, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
